NovaBay Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 2/6
NovaBay Pharmaceuticals has a total shareholder equity of $-617.0K and total debt of $696.0K, which brings its debt-to-equity ratio to -112.8%. Its total assets and total liabilities are $3.9M and $4.5M respectively.
Informazioni chiave
-112.8%
Rapporto debito/patrimonio netto
US$696.00k
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | US$751.00k |
| Patrimonio netto | -US$617.00k |
| Totale passività | US$4.54m |
| Totale attività | US$3.93m |
Aggiornamenti recenti sulla salute finanziaria
Analisi della posizione finanziaria
Passività a breve termine: NBY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Passività a lungo termine: NBY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: NBY has negative shareholder equity, which is a more serious situation than a high debt level.
Riduzione del debito: NBY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: NBY has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Previsione Cash Runway: NBY is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.